Here’s one stock I like that’s been hammering the Aviva share price

Aviva is one of my favourite insurers, but those who backed this stock instead have done much better.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Hiscox (LSE: HSX) crashed 15% on Thursday morning, after the international specialist insurer reported soaring claims in the third quarter.

Chief executive Bronek Masojada spoke of “significant catastrophe losses from storms in the US, the Caribbean and Japan,” with the firm having to set aside $165m for claims from Hurricane Dorian and Typhoons Faxai and Hagibis. That’s “materially in excess of the group’s catastrophe budget for the second half,” and fees and profit commissions should be around $25m lower at the end of the year too.

If that’s not enough natural disaster for one year, Hiscox also has exposure to the California wildfires, though at this stage it can’t tell us the size of any potential loss.

Price fall

The morning’s price drop has taken the shares down nearly 25% over the past 12 months, and with the potential for such catastrophes, I’m not surprised if investors shy away from insurers like Hiscox. But if you do invest in companies like this, you have to know you will take short-term hits from time to time, and only buy if you think the shares are good value for the long term. That’s especially important with disaster insurance, which must suffer from the worst short-term unpredictability in any sector.

So what’s Hiscox done for those long-term investors who understand the risk? Even after the decline of 2019, over five years, the Hiscox price is up 55% compared to the FTSE 100‘s 11%. Dividend yields have varied between 2% and 3%, so that’s a very good overall return.

If this is the kind of insurance sub-sector for you, the current weakness might even provide a good buying opportunity.

Safer

I prefer less specialised general insurers like Aviva (LSE: AV) myself. I see them as safer and more likely to provide reliable and progressive dividends, which is a core requirement for me.

Saying that, Aviva hasn’t exactly set the world on fire over the past five years, with its 17% share price loss comparing badly to a simple index tracker, never mind to Hiscox’s strong gain. On the plus side, Aviva has been paying bigger dividends, with its yield reaching 8% in 2018 — and the current year is forecast to deliver 7.4%.

But the shares are on very low P/E multiples of only around seven, so big investors are clearly not convinced by the Aviva proposition at the moment. I think that’s for a number of reasons.

Complexity

One is the complexity that is Aviva. The company, under the leadership of new CEO Maurice Tulloch, is in the process of splitting out its two UK businesses, general insurance and life insurance. It’s no easy task and could take some time, and such a serious restructuring clouds the horizon with the kind of uncertainty that the City hates.

Plans to cut costs by up to £300m lead to fears of pressure on the dividend too. After all, when a company needs to rein in its cash outflows, I usually advocate a careful look at the dividend. But it is well covered, and I’m relatively upbeat about it.

I can see the Aviva share price remaining low until some clarity emerges, but I still see it as a top income buy and I’m happy to keep pocketing my dividends.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft owns shares of Aviva. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »

Investing Articles

The Meta share price falls 10% on weak Q2 guidance — should investors consider buying?

The Meta Platforms' share price is down 10% after the company reported Q1 earnings per share growth of 117%. Does…

Read more »

Investing Articles

This FTSE 250 defence stock looks like a hidden growth gem to me

With countries hiking defence spending as the world grows more insecure, this FTSE 250 firm has seen surging orders and…

Read more »